Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent manner

This publication has 41 references indexed in Scilit:

• The deficiency ofAkt1is sufficient to suppress tumor development inPten^+/−mice
  Genes & Development, 2006
• Akt Activates the Mammalian Target of Rapamycin by Regulating Cellular ATP Level and AMPK Activity
  Journal of Biological Chemistry, 2005
• mTOR Controls Cell Cycle Progression through Its Cell Growth Effectors S6K1 and 4E-BP1/Eukaryotic Translation Initiation Factor 4E
  Molecular and Cellular Biology, 2004
• AKT Activity Determines Sensitivity to Mammalian Target of Rapamycin (mTOR) Inhibitors by Regulating Cyclin D1 and c-myc Expression
  Journal of Biological Chemistry, 2004
• Targeting RAS signalling pathways in cancer therapy
  Nature Reviews Cancer, 2003
• Growth retardation and increased apoptosis in mice with homozygous disruption of the akt1 gene
  Genes & Development, 2001
• p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD
  Proceedings of the National Academy of Sciences, 2001
• The Akt kinase: Molecular determinants of oncogenicity
  Proceedings of the National Academy of Sciences, 1998
• Pten is essential for embryonic development and tumour suppression
  Nature Genetics, 1998
• 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway
  Genes & Development, 1998